Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials

Bibliographic Details
Main Authors: Christopher H. Van Dyck, Ryan S. O'Dell, Adam P. Mecca
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Online Access:https://doi.org/10.1002/trc2.12388
_version_ 1797774699843813376
author Christopher H. Van Dyck
Ryan S. O'Dell
Adam P. Mecca
author_facet Christopher H. Van Dyck
Ryan S. O'Dell
Adam P. Mecca
author_sort Christopher H. Van Dyck
collection DOAJ
first_indexed 2024-03-12T22:24:56Z
format Article
id doaj.art-aa14cf8aab5c4577aeab36a9090b8c73
institution Directory Open Access Journal
issn 2352-8737
language English
last_indexed 2024-03-12T22:24:56Z
publishDate 2023-04-01
publisher Wiley
record_format Article
series Alzheimer’s & Dementia: Translational Research & Clinical Interventions
spelling doaj.art-aa14cf8aab5c4577aeab36a9090b8c732023-07-22T06:46:06ZengWileyAlzheimer’s & Dementia: Translational Research & Clinical Interventions2352-87372023-04-0192n/an/a10.1002/trc2.12388Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trialsChristopher H. Van Dyck0Ryan S. O'Dell1Adam P. Mecca2Department of Psychiatry Alzheimer's Disease Research Unit, Yale School of Medicine New Haven Connecticut USADepartment of Psychiatry Alzheimer's Disease Research Unit, Yale School of Medicine New Haven Connecticut USADepartment of Psychiatry Alzheimer's Disease Research Unit, Yale School of Medicine New Haven Connecticut USAhttps://doi.org/10.1002/trc2.12388
spellingShingle Christopher H. Van Dyck
Ryan S. O'Dell
Adam P. Mecca
Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials
Alzheimer’s & Dementia: Translational Research & Clinical Interventions
title Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials
title_full Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials
title_fullStr Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials
title_full_unstemmed Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials
title_short Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials
title_sort disease severity and minimal clinically important differences in clinical outcome assessments for alzheimer s disease clinical trials
url https://doi.org/10.1002/trc2.12388
work_keys_str_mv AT christopherhvandyck diseaseseverityandminimalclinicallyimportantdifferencesinclinicaloutcomeassessmentsforalzheimersdiseaseclinicaltrials
AT ryansodell diseaseseverityandminimalclinicallyimportantdifferencesinclinicaloutcomeassessmentsforalzheimersdiseaseclinicaltrials
AT adampmecca diseaseseverityandminimalclinicallyimportantdifferencesinclinicaloutcomeassessmentsforalzheimersdiseaseclinicaltrials